CINECA IRIS Institutional Research Information System

ROLANDO, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6290
EU - Europa 3950
AS - Asia 1675
OC - Oceania 31
AF - Africa 27
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6183
CN - Cina 1034
IT - Italia 1023
IE - Irlanda 553
SE - Svezia 422
DE - Germania 408
UA - Ucraina 254
GB - Regno Unito 238
FR - Francia 204
PL - Polonia 161
FI - Finlandia 158
KR - Corea 149
AT - Austria 148
VN - Vietnam 146
DK - Danimarca 143
CA - Canada 94
JP - Giappone 89
IN - India 84
BE - Belgio 72
TW - Taiwan 39
RU - Federazione Russa 36
ES - Italia 29
HK - Hong Kong 27
TR - Turchia 26
AU - Australia 22
GR - Grecia 22
NL - Olanda 21
CH - Svizzera 14
MX - Messico 12
SN - Senegal 12
IR - Iran 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
BR - Brasile 9
ID - Indonesia 9
NZ - Nuova Zelanda 9
TH - Thailandia 8
MY - Malesia 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
EG - Egitto 6
EU - Europa 5
JO - Giordania 5
SG - Singapore 5
AL - Albania 4
BG - Bulgaria 4
HU - Ungheria 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
CO - Colombia 3
IL - Israele 3
IQ - Iraq 3
PK - Pakistan 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
AF - Afghanistan, Repubblica islamica di 2
CL - Cile 2
CY - Cipro 2
EC - Ecuador 2
MD - Moldavia 2
MU - Mauritius 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
HR - Croazia 1
LV - Lettonia 1
MK - Macedonia 1
MW - Malawi 1
NG - Nigeria 1
RS - Serbia 1
VE - Venezuela 1
Totale 12003
Salva come PNG Salva come JPEG
Città #
Chandler 798
Ann Arbor 752
Fairfield 640
Dublin 550
Beijing 494
Torino 346
Woodbridge 333
Houston 328
Seattle 261
Ashburn 248
Wilmington 245
Cambridge 207
Jacksonville 173
Pisa 172
Nyköping 166
Dearborn 165
Warsaw 154
Vienna 143
Medford 126
Princeton 122
Redwood City 121
Villeurbanne 114
Dong Ket 109
Brussels 70
Turin 61
Fremont 60
Frankfurt am Main 56
Hangzhou 56
Munich 52
Shanghai 49
Boston 48
Guangzhou 39
Nanjing 37
San Diego 37
Milan 36
Taipei 35
Ottawa 31
Boardman 30
Toronto 30
Tokyo 25
Shenyang 24
Jinan 22
Zhengzhou 21
Copenhagen 20
Verona 20
Norwalk 19
Leinì 18
Siena 18
Wuhan 18
Xian 18
Hefei 17
Phoenix 16
Kunming 14
Seongnam 14
Upper Marlboro 14
Changsha 13
Nanchang 13
Hebei 12
Lansing 12
Seoul 12
Falls Church 11
Nottingham 11
Rome 11
Buffalo 10
Chengdu 10
Lachine 10
Silver Spring 10
Catania 9
Central 9
Central District 9
Changchun 9
Florence 9
Paris 9
Toledo 9
Alessandria 8
Mountain View 8
Nürnberg 8
Philadelphia 8
Bari 7
Bologna 7
Dallas 7
Fuzhou 7
Hanover 7
London 7
Tianjin 7
Birmingham 6
Jakarta 6
Newcastle 6
Ardabil 5
Carmagnola 5
Granada 5
Nanning 5
Nashville 5
Woodside 5
Amsterdam 4
Bangkok 4
Chennai 4
Chioggia 4
Chongqing 4
Düsseldorf 4
Totale 8143
Salva come PNG Salva come JPEG
Nome #
1,2,5-Oxadiazole analogues of leflunomide and related compounds 418
Quinone based nitric oxide donating compounds 398
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 371
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition 303
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance 270
New furoxan derivatives for the treatment of ocular hypertension 254
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 254
NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease 243
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins 238
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 233
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 222
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity 214
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 211
Doxorubicin-antioxidant multitarget drugs 203
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells 203
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 199
Edaravone derivatives containing NO-donor functions 196
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 188
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues 176
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 170
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 157
New nitric oxide or hydrogen sulfide releasing aspirins 156
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells 153
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria 143
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 138
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan 134
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells 127
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 125
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 124
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 123
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 123
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 121
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 120
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells 119
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 117
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 114
A new class of NO-donor H3-Antagonists 113
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 112
Multitarget Drugs: Focus on the NO-donor hybrid drugs 112
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells 112
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 110
Carnosine analogues containing Phenol substructures 108
Amphiphilic NO-Donor Antioxidants 108
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents 106
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 106
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 106
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni 102
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells 102
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 98
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors 95
4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site 95
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 92
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 89
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells. 89
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 88
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 85
Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies 84
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma 83
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 83
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 80
DNA-targeted NO release photoregulated by green light 80
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents 77
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 77
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 76
NO-donor Carnosine Derivatives As Potential Neuroprotective Agents 76
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 76
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 75
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 73
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety 72
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 71
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 68
NO-DONOR 1,4-DIHYDROPYRIDINE ANALOGUES OF AMLODIPINE 67
PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING A NEW ANTHRACYCLINE DERIVATIVE 66
Identification of 2,3-diaminophenazine and o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 65
No-donor phenols: a study of their antioxidant activity 63
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 63
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells 63
Physicochemical profiling of Sartans: detailed study of ionisation constants and distribution coefficients 63
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY 62
Multitarget Drugs: No-Donor Doxorubicins 62
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 62
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 60
New class of NO-donor soluble aspirins 54
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE 54
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER 54
New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold 54
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 53
Unsymmetrically Substituted Furoxans. Part 19. Methyl and Phenylfuroxansulfonic Acids and Related Sulfonamides 52
Novel NO-donor Doxorubicins 52
Vasodilating profile of a new series of analogues of GTN 49
Synthesis of NO-Donor Bisphosphonates and Their in Vitro Action on Bone Resorption 49
Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters 47
Multitarget drugs: NO-donor doxorubicins 46
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production 45
Focus on recent approaches for the development of new NO-donors 43
New No-donor aspirin derivatives 43
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties 43
Regioselective N‐Alkylation of Ethyl 4‐Benzyloxy‐1,2,3‐triazolecarboxylate: A Useful Tool for the Synthesis of Carboxylic Acid Bioisosteres 43
Preliminary ADME/PK studies of new hDHODH inhibitors effective for treatment of acute myeloid leukaemia (AML) 43
Preparation and characterization of liposomes containing a new anthracycline derivative. 42
Totale 11799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21810
article - articoli 0
book - libri 0
conference - conferenze 3315
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201873 0000 00 00 00073
2018/20191360 41335843 6883 82196 49153399155
2019/20202383 8289130288 167282 238181 272281196177
2020/20211741 126135109108 150106 121137 216153128252
2021/20222178 117119162215 11882 147134 80165493346
2022/20232531 23425575228 207594 327160 2311191010
Totale 12431